Estrogen withdrawal, increased breast cancer risk and the KRAS-variant

The KRAS-variant is a biologically functional, microRNA binding site variant, which predicts increased cancer risk especially for women. Because external exposures, such as chemotherapy, differentially impact the effect of this mutation, we evaluated the association of estrogen exposures, breast can...

Descripción completa

Detalles Bibliográficos
Autores principales: McVeigh, Terri P, Jung, Song-Yi, Kerin, Michael J, Salzman, David W, Nallur, Sunitha, Nemec, Antonio A, Dookwah, Michelle, Sadofsky, Jackie, Paranjape, Trupti, Kelly, Olivia, Chan, Elcie, Miller, Nicola, Sweeney, Karl J, Zelterman, Daniel, Sweasy, Joann, Pilarski, Robert, Telesca, Donatello, Slack, Frank J, Weidhaas, Joanne B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614527/
https://www.ncbi.nlm.nih.gov/pubmed/25961464
http://dx.doi.org/10.1080/15384101.2015.1041694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614527/
https://www.ncbi.nlm.nih.gov/pubmed/25961464
http://dx.doi.org/10.1080/15384101.2015.1041694

Ejemplares similares